Literature DB >> 22439922

[Ear, nose and throat manifestations of Wegener's granulomatosis (granulomatosis with polyangiitis)].

Carmelo Morales-Angulo1, Roberto García-Zornoza, Sergio Obeso-Agüera, Jaime Calvo-Alén, Miguel A González-Gay.   

Abstract

INTRODUCTION AND
OBJECTIVES: Granulomatosis with polyangiitis (GPA), previously called Wegener's granulomatosis, is a small vessel vasculitis often associated with clinical head and neck manifestations, which are sometimes the presenting symptoms of the disease. The aim of our study was to identify ear, nose and throat (ENT) manifestations associated with GPA and propose a work-up for the management and diagnosis for patients with suspicion or confirmed diagnosis of this ENT pathology. PATIENTS AND METHODS: Retrospective review of the medical records of all patients diagnosed with GPA who were seen at the Department of Otolaryngology from a tertiary public hospital in Cantabria (Spain) over a 20-year period. Clinical and laboratory data, in particular those concerning ENT manifestations, were retrieved from the patients' medical records.
RESULTS: Twenty-five patients (age range: 30-81 years) were included in the study. Of these, 88% had ENT manifestations at some point in the course of the disease. In 28% of the cases, ENT features were the presenting manifestations. The most frequent ENT manifestations were sinonasal symptoms (52%), followed by otological manifestations (32%).
CONCLUSIONS: Patients with GPA often present with clinical ENT manifestations. Consequently, routine ENT physical examination must be performed in patients with suspected vasculitis to establish a diagnosis of GPA or to better determine the degree of organ system involvement in patients with GPA.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22439922     DOI: 10.1016/j.otorri.2011.12.002

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  7 in total

1.  Clinical aspects of granulomatosis with polyangiitis affecting the head and neck.

Authors:  Andreas Knopf; Adam Chaker; Thomas Stark; Benedikt Hofauer; Tobias Lahmer; Klaus Thürmel; Murat Bas
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-09       Impact factor: 2.503

2.  Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener's granulomatosis), or systemic lupus erythematosus.

Authors:  Torsten Rahne; Franziska Clauß; Stefan K Plontke; Gernot Keyßer
Journal:  Clin Rheumatol       Date:  2017-04-28       Impact factor: 2.980

3.  Granulomatosis with Polyangiitis with Bilateral Facial Palsy and Severe Mixed Hearing Loss.

Authors:  Agnieszka Wawrzecka; Anna Szymańska; Radosław Jeleniewicz; Marcin Szymański
Journal:  Case Rep Otolaryngol       Date:  2016-07-14

4.  A destructive centrofacial granuloma: Case report.

Authors:  Zineb Tazi Saoud; Fatima Zahra Elfatoiki; Soumiya Chiheb
Journal:  Ann Med Surg (Lond)       Date:  2022-02-08

5.  Bilateral facial palsy in rapidly progressive course of Wegener's granulomatosis: a case report.

Authors:  Anna Roszkowska; Monika Morawska-Kochman; Hanna Temporale; Małgorzata Sikorska-Żuk; Tomasz Kręcicki
Journal:  Case Rep Otolaryngol       Date:  2013-09-25

Review 6.  Granulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current Knowledge.

Authors:  Joanna Wojciechowska; Wojciech Krajewski; Piotr Krajewski; Tomasz Kręcicki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-03-07       Impact factor: 3.372

7.  Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity.

Authors:  Roser Solans-Laqué; Guadalupe Fraile; Monica Rodriguez-Carballeira; Luis Caminal; Maria J Castillo; Ferran Martínez-Valle; Luis Sáez; Juan J Rios; Xavier Solanich; Joaquim Oristrell; Francisco Pasquau; Eva Fonseca; Monica Zamora; Jose L Callejas; Begoña Frutos; Monica Abdilla; Patricia Fanlo; Isabel García-Sánchez; Miguel López-Dupla; Bernardo Sopeña; Almudena Pérez-Iglesias; Josep A Bosch
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.